Spravato® (esketamine) is an FDA-approved prescription nasal spray used to treat adults with treatment-resistant depression.
At Shine Wellness, Spravato® treatment is provided in our clinic, where individuals have access to private rooms and care tailored to their individual needs. Each patient's treatment experience is adjusted according to their needs and clinical assessment.
Some people continue to experience symptoms of depression despite previous treatment.
If you've tried depression treatments without adequate improvement, additional treatment options may be worth discussing with a healthcare provider.
Spravato® is one option that may be considered for adults with treatment-resistant depression.
Spravato® is a prescription nasal spray used to treat adults with treatment-resistant depression. It is administered under the supervision of a healthcare provider in a certified treatment setting.
Your provider will review your medical and treatment history to determine whether Spravato® may be appropriate for you.
Spravato® may be considered for adults with treatment-resistant depression.
Your provider will review:
Treatment is considered based on individual clinical needs, with the goal of providing it when appropriate rather than unnecessarily.
Discuss your symptoms, treatment history, and medical history with a Shine provider.
Spravato® is administered as a nasal spray under healthcare-provider supervision in the clinic.
You will remain at the treatment center for monitoring after administration.
Your provider will evaluate your response and discuss your ongoing treatment plan.
Care based on your individual needs and treatment history.
Spravato® treatment is provided under healthcare-provider supervision.
A supportive environment throughout your treatment experience, with individual rooms available for treatment.
Evaluation, treatment, and follow-up in one care setting.
Spravato® has important safety considerations and is available only through the Spravato® REMS Program. Patients are monitored after treatment because Spravato® can cause effects such as sedation, dissociation, and increases in blood pressure.
You should not drive or operate machinery until the next day after a restful sleep, according to the prescribing information.
